Schroder Investment Management Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.35M | Sell |
38,648
-20,180
| -34% | -$3.86M | 0.01% | 703 |
|
|
2026
Q1 | $10.8M | Buy |
58,828
+1,556
| +3% | +$287K | 0.01% | 640 |
|
|
2025
Q4 | $10.1M | Sell |
57,272
-4,849
| -8% | -$792K | 0.01% | 632 |
|
|
2025
Q3 | $8.61M | Buy |
62,121
+48,354
| +351% | +$6.54M | 0.01% | 688 |
|
|
2025
Q2 | $1.73M | Sell |
13,767
-46,568
| -77% | -$5.8M | ﹤0.01% | 932 |
|
|
2025
Q1 | $8.35M | Buy |
60,335
+17,720
| +42% | +$2.53M | 0.01% | 674 |
|
|
2024
Q4 | $6.4M | Sell |
42,615
-21,444
| -33% | -$3.62M | 0.01% | 726 |
|
|
2024
Q3 | $12.5M | Buy |
64,059
+28,079
| +78% | +$5.87M | 0.01% | 621 |
|
|
2024
Q2 | $8.34M | Sell |
35,980
-43,509
| -55% | -$9.46M | 0.01% | 666 |
|
|
2024
Q1 | $17.1M | Sell |
79,489
-13,142
| -14% | -$3.08M | 0.02% | 530 |
|
|
2023
Q4 | $24M | Buy |
92,631
+37,948
| +69% | +$9.32M | 0.03% | 439 |
|
|
2023
Q3 | $14.1M | Sell |
54,683
-21,277
| -28% | -$5.69M | 0.02% | 536 |
|
|
2023
Q2 | $21.6M | Buy |
75,960
+1,891
| +3% | +$563K | 0.03% | 454 |
|
|
2023
Q1 | $20.6M | Buy |
74,069
+56,560
| +323% | +$15.6M | 0.03% | 463 |
|
|
2022
Q4 | $4.85M | Buy |
17,509
+320
| +2% | +$90.4K | 0.01% | 786 |
|
|
2022
Q3 | $4.59M | Sell |
17,189
-409
| -2% | -$86.9K | 0.01% | 790 |
|
|
2022
Q2 | $3.61M | Buy |
17,598
+2,909
| +20% | +$595K | 0.01% | 862 |
|
|
2022
Q1 | $3.1M | Buy |
14,689
+4,935
| +51% | +$1.07M | ﹤0.01% | 942 |
|
|
2021
Q4 | $2.34M | Sell |
9,754
-997
| -9% | -$256K | ﹤0.01% | 902 |
|
|
2021
Q3 | $3.04M | Sell |
10,751
-2,135
| -17% | -$700K | ﹤0.01% | 889 |
|
|
2021
Q2 | $4.46M | Sell |
12,886
-3,946
| -23% | -$1.2M | 0.01% | 849 |
|
|
2021
Q1 | $4.71M | Sell |
16,832
-262,776
| -94% | -$70.9M | 0.01% | 832 |
|
|
2020
Q4 | $68.5M | Sell |
279,608
-162,832
| -37% | -$42M | 0.1% | 201 |
|
|
2020
Q3 | $123M | Sell |
442,440
-160,597
| -27% | -$44.8M | 0.2% | 104 |
|
|
2020
Q2 | $161M | Buy |
603,037
+89,405
| +17% | +$26.9M | 0.29% | 70 |
|
|
2020
Q1 | $160M | Buy |
513,632
+27,523
| +6% | +$8.35M | 0.34% | 62 |
|
|
2019
Q4 | $144M | Sell |
486,109
-11,142
| -2% | -$3.09M | 0.24% | 92 |
|
|
2019
Q3 | $114M | Buy |
497,251
+49,701
| +11% | +$11.6M | 0.2% | 103 |
|
|
2019
Q2 | $105M | Buy |
447,550
+53,605
| +14% | +$12.4M | 0.19% | 118 |
|
|
2019
Q1 | $93.1M | Sell |
393,945
-22,535
| -5% | -$7.1M | 0.17% | 135 |
|
|
2018
Q4 | $125K | Sell |
416,480
-65,125
| -14% | -$20.8M | 0.23% | 89 |
|
|
2018
Q3 | $170M | Sell |
481,605
-200,272
| -29% | -$69M | 0.29% | 74 |
|
|
2018
Q2 | $197M | Sell |
681,877
-222,389
| -25% | -$62.5M | 0.34% | 65 |
|
|
2018
Q1 | $248M | Buy |
904,266
+108,297
| +14% | +$33.6M | 0.43% | 46 |
|
|
2017
Q4 | $254M | Buy |
795,969
+300,498
| +61% | +$96.4M | 0.42% | 41 |
|
|
2017
Q3 | $154M | Buy |
495,471
+189,501
| +62% | +$56.1M | 0.27% | 82 |
|
|
2017
Q2 | $83.2M | Buy |
305,970
+84,981
| +38% | +$22.5M | 0.15% | 176 |
|
|
2017
Q1 | $59.5M | Sell |
220,989
-57,364
| -21% | -$16.2M | 0.11% | 240 |
|
|
2016
Q4 | $78.9M | Sell |
278,353
-240,572
| -46% | -$71.3M | 0.15% | 178 |
|
|
2016
Q3 | $162M | Buy |
518,925
+153,532
| +42% | +$45.5M | 0.3% | 70 |
|
|
2016
Q2 | $88.4M | Buy |
365,393
+275,497
| +306% | +$72.6M | 0.18% | 146 |
|
|
2016
Q1 | $22.9M | Sell |
89,896
-1,386
| -2% | -$366K | 0.05% | 429 |
|
|
2015
Q4 | $28M | Sell |
91,282
-292,447
| -76% | -$84M | 0.06% | 382 |
|
|
2015
Q3 | $112M | Buy |
383,729
+246,191
| +179% | +$81.3M | 0.24% | 110 |
|
|
2015
Q2 | $54.5M | Sell |
137,538
-55,977
| -29% | -$22.5M | 0.11% | 252 |
|
|
2015
Q1 | $83.2M | Buy |
193,515
+1,081
| +0.6% | +$426K | 0.16% | 163 |
|
|
2014
Q4 | $65.3M | Sell |
192,434
-19,855
| -9% | -$6.42M | 0.13% | 202 |
|
|
2014
Q3 | $70.2M | Sell |
212,289
-29,450
| -12% | -$9.71M | 0.09% | 206 |
|
|
2014
Q2 | $76.2M | Buy |
241,739
+168,461
| +230% | +$50.7M | 0.09% | 192 |
|
|
2014
Q1 | $22.4M | Buy |
73,278
+23,808
| +48% | +$7.56M | 0.03% | 461 |
|
|
2013
Q4 | $13.8M | Buy |
49,470
+3,000
| +6% | +$776K | 0.02% | 564 |
|
|
2013
Q3 | $11.2M | Sell |
46,470
-21,217
| -31% | -$4.75M | 0.03% | 606 |
|
|
2013
Q2 | $14.6M | Buy |
+67,687
| New | +$14.5M | 0.04% | 492 |
|
Other funds holding BIIB
Schroder Investment Management Group's BIIB Position: Q2 2026 in Review
Schroder Investment Management Group reduced its Biogen (BIIB) stake by 34% in Q2 2026, selling an estimated $3.86M and leaving 38,648 shares worth $8.35M. The position accounts for 0.01% of the portfolio, ranked #703.
Schroder Investment Management Group first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $254M in Q4 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Schroder Investment Management Group held 38,648 shares of Biogen worth $8.35M as of Q2 2026.
- Schroder Investment Management Group sold 20,180 Biogen shares in Q2 2026, an estimated $3.86M.
- Biogen made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #703 holding.
- Schroder Investment Management Group first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Schroder Investment Management Group's Biogen position peaked at $254M in Q4 2017.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.